Trial intelligence / Profile preview

Lidocaine vs Diclofenac Spray for Radial Artery Blood Gas Sampling Analgesia

NCT06918340Phase 4Active, not recruiting

Sponsor
Haydarpaşa Numune Training and Research Hospital
Start
Nov 2024
Primary completion
Dec 2024
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of lidocaine 10% oropharyngeal spray and diclofenac in procedural pain (3 arms), sponsored by Haydarpaşa Numune Training and Research Hospital. Primary endpoints: Visual Analogue Scale Pain Score and Perfusion Index. Started Nov 2024; status: active, not recruiting.

02

Drugs

lidocaine 10% oropharyngeal spraydiclofenac
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT06918340.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06918340.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call